Mesothelioma News Blog Archive "human antibody-receptor agonist trail mapatumumab and lexatumumab induce apoptosis in malignant mesothelioma and act in synergy with cisplatin

Background: The incidence of malignant pleural "mesothelioma" (MPM) is associated with exposure to asbestos, and projections indicate that the annual number of deaths in Western Europe due to MPM will increase until 2020. ... - continue reading...